BGLC

BioNexus Gene LabF

Nasdaq / Capital Goods

At close

2026-07-18

View Chart

Current thesis

Composite grade F from latest DB weights. Momentum 23.4 / Value 33.9

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta +0.0.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

— · Net —

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade F · Defensive

Confidence Medium · Net —

Why

Momentum23 · Δ7d -

Value34 · Δ7d +0.0

SentimentN/A · Δ7d -

So what

Weak posture. Prioritize risk control and patience.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Value · See fundamentals

Momentum

40% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

60% active weight

Current posture

7d trendFlat

Δ7d

+0.0

Δ21d

+0.1

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade F. Momentum 23.4 / Value 33.9

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$4.01M

Beta

2.28

Shares Out

2.42M

P/E (TTM) · Derived

-1.0

P/S (TTM)

1.02

P/FCF (TTM) · Derived

-2.43

Rev YoY

-98.9%

EPS YoY

-35.2%

Gross Margin

+13.0%

Op Margin

-24.8%

Net Debt

-$3.86M

Current Ratio

6.52

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology